
V2X is rated an opportunistic BUY for long-term investors at $65–$72, following a 20% sell-off despite strong earnings and guidance. VVX's backlog remains robust at $12.7 billion, with two recent $500 million contract wins and double-digit growth in its Pacific theater segment. Full-year 2026 guidance was raised across revenue, adjusted EBITDA, and EPS, supported by margin-accretive contract awards and ongoing deleveraging.










